Asset Details
Do you wish to reserve the book?
EP4 Agonist Inhibits Lipopolysaccharide-Induced Mucus Secretion in Airway Epithelial Cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
EP4 Agonist Inhibits Lipopolysaccharide-Induced Mucus Secretion in Airway Epithelial Cells
Do you wish to request the book?
EP4 Agonist Inhibits Lipopolysaccharide-Induced Mucus Secretion in Airway Epithelial Cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
EP4 Agonist Inhibits Lipopolysaccharide-Induced Mucus Secretion in Airway Epithelial Cells
2008
Overview
Objectives:
We examined the in vivo effects of agonists for prostaglandin E2 receptors (EP1, EP2, EP3, and EP4) on mucus hypersecretion. We also examined the in vitro effects of EP agonists on airway epithelial cells.
Methods:
For the in vivo study, we induced hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium by intranasal lipopolysaccharide (LPS) instillation. For the in vitro study, we used NCI-H292 cells and cultured human nasal epithelial cells.
Results:
Subcutaneous injection of the EP4 agonist (1 to 100 μg/kg) dose-dependently inhibited LPS-induced mucus production and neutrophil infiltration. The EP3 agonist (100 μg/kg) also had some inhibitory effects on mucus production, whereas the EP1 and EP2 agonists showed no effect. The LPS-induced mucus secretion was significantly inhibited by the EP3 and EP4 agonists at 10−6 mol/L in cultured epithelial cells. The LPS-induced interleukin-8 secretion was also inhibited by the EP3 and EP4 agonists.
Conclusions:
These results indicate that the EP4 agonist inhibited LPS-induced airway mucus hypersecretion directly or indirectly through the suppression of interleukin-8 secretion and neutrophil infiltration.
Publisher
SAGE Publications,Annals Publishing Compagny,SAGE PUBLICATIONS, INC
Subject
/ Biological and medical sciences
/ Carcinoma, Mucoepidermoid - genetics
/ Carcinoma, Mucoepidermoid - pathology
/ Carcinoma, Mucoepidermoid - secretion
/ Dinoprostone - analogs & derivatives
/ Gene Expression Regulation, Neoplastic
/ Lipopolysaccharides - toxicity
/ Male
/ Otorhinolaryngology. Stomatology
/ Rats
/ Receptors, Prostaglandin E - agonists
/ Receptors, Prostaglandin E - biosynthesis
/ Receptors, Prostaglandin E - genetics
/ Receptors, Prostaglandin E, EP4 Subtype
/ Respiratory Hypersensitivity - chemically induced
/ Respiratory Hypersensitivity - genetics
/ Respiratory Hypersensitivity - metabolism
